Navigation Links
VOICE study will continue as it considers what action to take after results of 2 trials
Date:7/13/2011

he DSMB found the results so compelling that it recommended that it stop testing in the placebo group. The research team will be making arrangements so that participants who had been randomly assigned to take a placebo tablet can instead receive one of the study's active study products. Participants in the other two groups will continue to be followed.

In the second study, a smaller trial that involved 1,200 heterosexual men and women in Botswana, researchers from the U.S. Centers for Disease Control and Prevention (CDC) found that 62.6 percent fewer HIV infections had occurred in the group of participants assigned to take Truvada than in the placebo group. The CDC team will be reporting more details about the findings of the study, known as TDF2, at the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Rome next week.

Both sets of results bolster the findings of iPrEx, which late last year provided the first evidence that oral PrEP can help prevent HIV. iPrEx found Truvada together with a comprehensive HIV prevention package was safe and 44 (43.8) percent more effective than a placebo tablet for protecting against HIV in men who have sex with men. The two studies' favorable results also raise more questions about what happened with FEM-PrEP. Two months ago, researchers announced the trial would be stopping earlier than planned because an interim review of the study's progress by its data monitoring committee determined that even if the study were to continue, it would not be able to conclude whether or not Truvada is effective in its population of women. The study team is still collecting data. A final report is not expected until late this year or early 2012.

Few conclusions can be drawn from the CDC study concerning the effectiveness of Truvada specifically in women. And although Partners PrEP found tenofovir and Truvada worked well for both men and women, the study provides more information abo
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement
2. The Voice of Compassionate Cancer Treatment Just Got Louder: Website Provides Resources and a Call to Action for the Medical Community
3. Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform
4. Larynx preservation treatments result in low instance of severe voice disability, nutritional dysfunction
5. Independent Womens Voice Releases Health Care Poll
6. VoiceNation Helps Non-Profits Gather Funding for Those in Need
7. Infants Sensitivity to Voices May Develop by 7 Months
8. The Scarlet I: Infertility survivors lend voices to U of I profs new book
9. Voice Analysis May Allow Early Detection of Parkinsons
10. More than 60 percent of teachers have voice problems
11. Now Hiring: VoipWalker, Inc. DBA VoiceWalker, Experiences Significant Up-Tick in Business, Enters Hiring Mode
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Ramon, CA (PRWEB) July 30, 2014 ... the ancient redwood forests of the Pomo Indians located ... The Pomo called the river Shabaikai, meaning ‘crooked snake’. ... its labor strife and the violence of prohibition and ... Club at Russian River. Here, the most powerful men ...
(Date:7/30/2014)... 2014 With the recent May 21st opening ... Ground Zero Museum Workshop in the Meatpacking District has been ... Museum Workshop's Carole Barnes, "We have had to re-write the ... travel sites who sell us so tourists don't confuse the ... to what we do and what the new Museum does ...
(Date:7/30/2014)... for Vedic Studies (WAVES) conference is coming to Fairfield, ... 31 through Sunday, August 3. To watch the main ... the first time such a large and diverse group ... to explore the relevance of ancient Vedic knowledge in ... states of consciousness, and reflections on the various Vedic ...
(Date:7/30/2014)... 2014 Today, Gen. Arthur T. Dean, ... America (CADCA) , the nation’s leading substance abuse prevention ... New York Times Editorial Board’s call for ... , “CADCA is disappointed in the New York ... national marijuana legalization. The move is shortsighted and completely ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Clues to whether a ... simple blood test, a new study suggests. Chemical changes ... hormones may help spur suicidal thoughts and behaviors, the study,s ... help alert doctors to a patient,s risk for suicide, they ... but we have been stymied in our prevention efforts because ...
Breaking Medicine News(10 mins):Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 3Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 4Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 5Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3
... ... Circulation Heart Failure, a journal of the American Heart Association, ... is more accurate than the current listing criteria for heart transplantation ... intervention. The study conclusions reinforce the science behind the Shape-HFTM Cardiopulmonary ...
... ... based company, providing residential and commercial pest control services, is proud to announce the launch ... ... this week, Clark Pest Control’s 2010 television advertising campaign will air on stations across California ...
... disabilities related to mobility increased significantly from 1997 to 2007, ... among Americans ages 65 and over, according to a new ... Researchers found a rise in the proportion of Americans ... need for help in daily personal care activities such as ...
... drink, study finds , MONDAY, April 5 (HealthDay News) -- ... imbibe a bit too much themselves. , And the same ... relatives are more likely not to consume alcohol themselves, a ... behavior more than would be predicted by chance alone," said ...
... still needs testing , MONDAY, April 5 (HealthDay News) ... have found that tick-borne transmission might be preventable by ... infection. , Though to date the strategy has been ... toward development of a vaccine that reduces the risk ...
... Addiction rehabilitation center ... available at YouTube , ... TX (Vocus) April 5, 2010 -- With the numerous addiction rehabilitation programs available today, many ... program offering is best suited for their individual needs. In a new video available to ...
Cached Medicine News:Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 2Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 3Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 4Health News:Marysville Girl Stars in TV Advertising Campaign 2Health News:Middle-aged Americans reporting more mobility related disabilities, study finds 2Health News:Middle-aged Americans reporting more mobility related disabilities, study finds 3Health News:Your Social Network Affects Your Drinking Habits 2Health News:Your Social Network Affects Your Drinking Habits 3Health News:Genetic Engineering Raises Hope for Lyme Disease Vaccine 2Health News:Genetic Engineering Raises Hope for Lyme Disease Vaccine 3Health News:Drug Rehab Treatment Center Explains Rehabilitation Program Using YouTube 2
(Date:7/30/2014)... 30, 2014 Stryker brand ambassadors Fred Funk ... 3M Championship Champions Tour event near Minneapolis, MN ... Blaine . Stryker is the official joint replacement products company ... Friday, August 1 st through Sunday, August 3 rd , ... on-site joint health destination located in the Pioneer Press Expo tent ...
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... and SAN DIEGO , July 30, 2014 ... ARNA ) announced today that an article based on post-hoc ... entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise ... published in the online issue of Obesity , the ... of these analyses was to identify whether there is an ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... June 2, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: ... presentation at the Jefferies 2011 Global Healthcare Conference in New ... Time. Bruce Cozadd, the company,s chairman and chief executive officer, ... live webcast of presentation may be accessed from the Investors ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Bisaro, Watson,s President and Chief Executive Officer, will provide ... the 2011 Goldman Sachs 32nd Annual Global Healthcare Conference ... at the Terranea Resort in Rancho Palos Verdes, California. ...
Cached Medicine Technology:
HRT II is the smallest scanning laser ever, light, portable and ready for telemedicine....
...
... Horizon Phacoemulsification System is a ... Lightweight and portable, it offers ... a small console. It also ... perform anterior segment surgery. These ...
... tool designed for ophthalmic surgeons. ... reliable, safe and easy to ... (one year for ultrasonic handpiece). ... console, phaco handpiece, foot pedal, ...
Medicine Products: